4//SEC Filing
Savarese John 4
Accession 0001209191-12-027716
CIK 0001411861other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 5:30 PM ET
Size
14.1 KB
Accession
0001209191-12-027716
Insider Transaction Report
Form 4
Savarese John
Director
Transactions
- Sale
Common Stock
2012-05-10$25.48/sh−82,253$2,095,650→ 0 total(indirect: By Montreux Equity Partners IV, L.P.) - Sale
Common Stock
2012-05-09$26.04/sh−18,653$485,651→ 4,000 total - Other
Common Stock
2012-05-09−24,197→ 0 total(indirect: By Montreux IV Associates, L.L.C.) - Sale
Common Stock
2012-05-09$26.06/sh−437,542$11,401,163→ 800,708 total(indirect: By Montreux Equity Partners IV, L.P.) - Sale
Common Stock
2012-05-10$24.68/sh−718,455$17,732,116→ 82,253 total(indirect: By Montreux Equity Partners IV, L.P.)
Footnotes (7)
- [F1]The price in column 4 is a weighted average price per share. The prices actually paid ranged from $26.00 to $26.21 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- [F2]Montreux IV Associates, L.L.C. distributed the shares to its members on a pro rata basis. The reporting person is a managing member of Montreux Equity Management IV, LLC, which is the managing member of Montreux IV Associates, L.L.C., but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- [F3]The reporting person is a managing member of Montreux Equity Management IV, LLC, the managing member of Montreux IV Associates, L.L.C.
- [F4]The price in column 4 is a weighted average price per share. The prices actually paid ranged from $26.00 to $26.51 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- [F5]The reporting person is a managing member of Montreux Equity Management IV, LLC, the general partner of Montreux Equity Partners IV, L.P., but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- [F6]The price in column 4 is a weighted average price per share. The prices actually paid ranged from $24.15 to $25.15 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- [F7]The price in column 4 is a weighted average price per share. The prices actually paid ranged from $25.16 to $26.11 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
Documents
Issuer
MAKO Surgical Corp.
CIK 0001411861
Entity typeother
Related Parties
1- filerCIK 0001398221
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 5:30 PM ET
- Size
- 14.1 KB